Clinical Trial Update: Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of modified house dust mite allergen extracts for specific immunotherapy in allergic rhinitis; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Modified House Dust Mite Allergen Extracts for Specific Immunotherapy

Snippet

Sponsor: Roxall Medizin | Conditions: Allergic Rhinitis | Phase 3 | Status: UNKNOWN